These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 7947737

  • 1. Phosphorylation sites in ligand-induced and ligand-independent activation of the progesterone receptor.
    Chauchereau A, Cohen-Solal K, Jolivet A, Bailly A, Milgrom E.
    Biochemistry; 1994 Nov 15; 33(45):13295-303. PubMed ID: 7947737
    [Abstract] [Full Text] [Related]

  • 2. Characterization of ligand binding, DNA binding and phosphorylation of progesterone receptor by two novel progesterone receptor antagonist ligands.
    Hurd C, Underwood B, Herman M, Iwasaki K, Kloosterboer HJ, Dinda S, Moudgil VK.
    Mol Cell Biochem; 1997 Oct 15; 175(1-2):205-12. PubMed ID: 9350053
    [Abstract] [Full Text] [Related]

  • 3. Progesterone receptor and the mechanism of action of progesterone antagonists.
    Edwards DP, Altmann M, DeMarzo A, Zhang Y, Weigel NL, Beck CA.
    J Steroid Biochem Mol Biol; 1995 Jun 15; 53(1-6):449-58. PubMed ID: 7626494
    [Abstract] [Full Text] [Related]

  • 4. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
    Leonhardt SA, Altmann M, Edwards DP.
    Mol Endocrinol; 1998 Dec 15; 12(12):1914-30. PubMed ID: 9849965
    [Abstract] [Full Text] [Related]

  • 5. Ionic and ligand-specific effects on the DNA binding of progesterone receptor bound to the synthetic progestin R5020 and the antiprogestin RU486.
    Chao CC, Thomas TJ, Ebede P, Gallo MA, Thomas T.
    Cancer Res; 1991 Aug 01; 51(15):3938-45. PubMed ID: 1855211
    [Abstract] [Full Text] [Related]

  • 6. Human progesterone receptor transformation and nuclear down-regulation are independent of phosphorylation.
    Sheridan PL, Krett NL, Gordon JA, Horwitz KB.
    Mol Endocrinol; 1988 Dec 01; 2(12):1329-42. PubMed ID: 3063956
    [Abstract] [Full Text] [Related]

  • 7. Agonist and antagonist-induced qualitative and quantitative alterations of progesterone receptor from breast cancer cells.
    Hurd C, Nag K, Khattree N, Alban P, Dinda S, Moudgil VK.
    Mol Cell Biochem; 1999 Sep 01; 199(1-2):49-56. PubMed ID: 10544951
    [Abstract] [Full Text] [Related]

  • 8. Effects of the steroid antagonist RU486 on dimerization of the human progesterone receptor.
    DeMarzo AM, Oñate SA, Nordeen SK, Edwards DP.
    Biochemistry; 1992 Nov 03; 31(43):10491-501. PubMed ID: 1420166
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
    Gass EK, Leonhardt SA, Nordeen SK, Edwards DP.
    Endocrinology; 1998 Apr 03; 139(4):1905-19. PubMed ID: 9528977
    [Abstract] [Full Text] [Related]

  • 14. R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism.
    Shatnawi A, Tran T, Ratnam M.
    Mol Endocrinol; 2007 Mar 03; 21(3):635-50. PubMed ID: 17192405
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors.
    Beck CA, Weigel NL, Edwards DP.
    Mol Endocrinol; 1992 Apr 03; 6(4):607-20. PubMed ID: 1316549
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-independent and DNA-dependent stages: analysis with zinc finger mutants and the progesterone antagonist ZK98299.
    Takimoto GS, Tasset DM, Eppert AC, Horwitz KB.
    Proc Natl Acad Sci U S A; 1992 Apr 01; 89(7):3050-4. PubMed ID: 1557412
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.